top of page


MAJI Moves to Cancel Over 15M Shares As It Pushes Toward Commercialization
Glioblastoma is one of medicine's most formidable enemies. It's a brain cancer so aggressive that for decades, even the most advanced...

Checkers
Sep 43 min read
Â
Â


Surging Volume Puts Exousia Pro (MAJI) in the Spotlight
After recording its highest trading volume in a year last Friday, now seems like a good time to pay attention to Exousia Pro ( OTC Pink...

Checkers
Mar 172 min read
Â
Â
bottom of page



